Avidity Biosciences (RNA) Insider Trading & Ownership $35.92 -0.79 (-2.15%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$36.44 +0.52 (+1.45%) As of 08/1/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avidity Biosciences (NASDAQ:RNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.83%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$15.15M Get RNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Avidity Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RNA Insider Buying and Selling by Quarter Avidity Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/17/2025Kathleen P GallagherInsiderSell911$30.24$27,548.64 6/11/2025W. Michael FlanaganInsiderSell20,000$32.88$657,600.00 6/2/2025Kathleen P GallagherInsiderSell5,875$32.48$190,820.00 5/1/2025Kathleen P GallagherInsiderSell5,875$32.40$190,350.00 4/1/2025Kathleen P GallagherInsiderSell5,875$27.83$163,501.25 3/20/2025Michael F MacleanCFOSell7,935$31.06$246,461.10 3/20/2025Sarah BoyceCEOSell31,540$31.06$979,632.40 3/20/2025Steven George HughesInsiderSell9,578$31.06$297,492.68 2/3/2025Kathleen P GallagherInsiderSell5,875$32.16$188,940.00 1/21/2025Arthur A LevinDirectorSell1,872$28.60$53,539.20 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/21/2025Michael F MacleanCFOSell3,287$28.59$93,975.33 1/21/2025Sarah BoyceCEOSell10,397$28.59$297,250.23 1/21/2025Teresa MccarthyInsiderSell2,959$28.59$84,597.81 12/18/2024Michael F MacleanCFOSell11,151$32.66$364,191.66 12/18/2024Sarah BoyceCEOSell31,855$32.66$1,040,384.30 12/18/2024W. Michael FlanaganInsiderSell12,742$32.66$416,153.72 12/16/2024Teresa MccarthyInsiderSell25,000$33.26$831,500.00 12/11/2024W. Michael FlanaganInsiderSell24,000$35.77$858,480.00 11/19/2024Arthur A LevinDirectorSell3,323$42.12$139,964.76 11/18/2024Teresa MccarthyInsiderSell25,000$41.14$1,028,500.00 10/21/2024Arthur A LevinDirectorSell5,000$46.63$233,150.00 10/16/2024Teresa MccarthyInsiderSell25,000$48.52$1,213,000.00 10/7/2024Tamar ThompsonDirectorSell30,000$44.98$1,349,400.00 9/23/2024Michael F MacleanCFOSell11,510$44.00$506,440.00 9/23/2024Sarah BoyceCEOSell32,880$44.00$1,446,720.00 9/23/2024Teresa MccarthyInsiderSell13,153$44.00$578,732.00 9/19/2024Arthur A LevinDirectorSell5,000$45.73$228,650.00 8/19/2024Arthur A LevinDirectorSell5,000$45.19$225,950.00 8/6/2024Sarah BoyceCEOSell28,000$43.35$1,213,800.00 (Data available from 1/1/2013 forward) RNA Insider Trading Activity - Frequently Asked Questions Who is on Avidity Biosciences' Insider Roster? The list of insiders at Avidity Biosciences includes Arthur A Levin, Kathleen P Gallagher, Michael F Maclean, Sarah Boyce, Steven George Hughes, Tamar Thompson, Teresa Mccarthy, and W. Michael Flanagan. Learn more on insiders at RNA. What percentage of Avidity Biosciences stock is owned by insiders? 3.83% of Avidity Biosciences stock is owned by insiders. Learn more on RNA's insider holdings. Which Avidity Biosciences insiders have been selling company stock? The following insiders have sold RNA shares in the last 24 months: Arthur A Levin ($4,130,616.86), Kathleen P Gallagher ($761,159.89), Michael F Maclean ($8,052,869.57), Sarah Boyce ($16,643,147.53), Steven George Hughes ($297,492.68), Tamar Thompson ($1,349,400.00), Teresa Mccarthy ($3,736,329.81), and W. Michael Flanagan ($1,974,060.49). How much insider selling is happening at Avidity Biosciences? Insiders have sold a total of 1,100,408 Avidity Biosciences shares in the last 24 months for a total of $36,945,076.83 sold. Avidity Biosciences Key ExecutivesDr. Troy Edward Wilson J.D. (Age 55)Ph.D., Co-Founder & Independent Chairman Compensation: $70kMs. Sarah Boyce (Age 52)President, CEO & Director Compensation: $998.88k1 recent tradesMr. Michael F. MacLean (Age 58)Chief Financial & Chief Business Officer Compensation: $674.74k1 recent tradesDr. W. Michael F. Flanagan Ph.D. (Age 61)Chief Scientific & Technical Officer Compensation: $675.22kMs. Teresa McCarthy (Age 60)Chief Human Resources Officer Compensation: $628.79kDr. Arthur A. Levin Ph.D. (Age 70)Distinguished Scientist, Strategic Leader & Director Compensation: $304.69kMr. Eric B. Mosbrooker (Age 57)Chief Strategy Officer Compensation: $45kProf. Mark E. Davis Ph.D.Scientific Founder, Member of Scientific Advisory Board and Member of Board of ManagersDr. Frank P. McCormick Ph.D. (Age 74)Scientific Founder & Member of Scientific Advisory Board Mr. Geoffrey M. Grande C.F.A.VP of Investor Relation & Corporate Communication More Insider Trading Tools from MarketBeat Related Companies GMAB Insider Ownership MRNA Insider Ownership VTRS Insider Ownership BBIO Insider Ownership VRNA Insider Ownership BPMC Insider Ownership ROIV Insider Ownership ELAN Insider Ownership RVMD Insider Ownership GRFS Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:RNA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avidity Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.